In this episode of Med Tech Talks, Robert Klupacs is joined by one of Australia’s most successful med tech expats, Dr Jeremy Buzzard,  CEO of Enteralia Bioscience and co-founder of Induction Bio.  

Jeremy also notably was a partner at McKinsey and Co., where he led the firm’s global healthcare strategy and corporate finance practice.

Jeremy is on the record as being involved in more than 25 major transactions that were executed with an aggregate value of $56Bn USD.

In this episode, you will hear about:

• The missions of Enteralia Biosciences and Induction Bio
• Jeremy's reflections on his time at Harvard University and McKinsey and Co.
•  His thoughts on the key learnings Australia can take from the US med tech market to improve our innovation outcomes.  

Learn more about:

• Enteralia Biosciences 

Updated version 05/08/22